Neurologic Manifestations and Outcome of West Nile Virus Infection

JAMA

Volumn 290, Issue 4, 2003, Pages 511-515

  Sejvar, James J ^a   Haddad, Maryam B ^c   Tierney, Bruce C ^c   Campbell, Grant L ^b   Marfin, Anthony A ^b   Van Gerpen, Jay A ^d   Fleischauer, Aaron ^c   Leis, A Arturo ^e   Stokic, Dobrivoje S ^e   Petersen, Lyle R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d OCHSNER CLINIC FOUNDATION   (United States)

^e METHODIST REHABILITATION CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY; FATIGUE; FEMALE; FLACCID PARALYSIS; FOLLOW UP; GAIT DISORDER; HEADACHE; HUMAN; LABORATORY TEST; LONG TERM CARE; MALE; MOTOR DYSFUNCTION; MUSCLE STRENGTH; MYALGIA; MYOCLONUS; NEUROLOGIC DISEASE; POLIOMYELITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SERODIAGNOSIS; STANDARD; VIRUS INFECTION; VIRUS MENINGITIS; WEST NILE FLAVIVIRUS; BLOOD; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; GLASGOW COMA SCALE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MUSCLE HYPOTONIA; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; VIROLOGY; VIRUS ENCEPHALITIS;

ACTIVITIES OF DAILY LIVING; ANTIBODIES, VIRAL; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ENCEPHALITIS, VIRAL; GLASGOW COMA SCALE; HOSPITALIZATION; HUMANS; MAGNETIC RESONANCE IMAGING; MENINGITIS, VIRAL; MOVEMENT DISORDERS; MUSCLE HYPOTONIA; MYOCLONUS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARALYSIS; TOMOGRAPHY, X-RAY COMPUTED; WEST NILE FEVER; WEST NILE VIRUS;

EID: 0038455694     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.4.511     Document Type: Article

References (35)

1. Campbell G, Marfin A, Lanciotti R, Gubler D. West Nile virus. Lancet Infect Dis. 2002;2:519-529.
2. Tsai T, Popovici F, Cernescu C, Campbell G, Nedelcu N. West Nile encephalitis epidemic in south-eastern Romania. Lancet. 1998;352:767-771.
3. Chowers M, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675-678.
4. Centers for Disease Control and Prevention. Serosurveys for West Nile virus infection - New York and Connecticut counties, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:37-39.
5. Platonov A, Shipulin G, Shipulina O, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis. 2001;7:128-132.
6. Mostashari F, Bunning M, Kitsutani P, et al. Epidemic West Nile encephalitis, New York, 1999. Lancet. 2001;358:254-255.
7. Asnis D, Conetta R, Teixeira A, Waldman G, Sampson B. The West Nile virus outbreak of 1999 in New York City. Clin infect Dis. 2000;30:413-418.
8. Han L, Popovici F, Alexander J, et al. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis. 1999;179:230-233.
9. Petrov V, Krasnova Y, Lvov D, et al. Clinical picture and epidemiology of West Nile fever in Volgograd Oblast (1999 and 2000) [in Russian]. Moscow Voprosy Virusologii. 2001;45:22-26.
10. Centers for Disease Control and Prevention. West Nile virus activity - United States, August 8-14, 2002, and Mississippi, July 1-August 14, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:708-709.
11. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-1814.
12. Martin D, Biggerstaff B, Allen B, et al. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagnostic Lab Immunol. 2002;9:544-549.
13. Martin D, Muth D, Brown T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol. 2000;381:823-826.
14. Centers for Disease Control and Prevention. Acute flaccid paralysis associated with West Nile virus infection - Mississippi and Louisiana, July-August 2002. MMWR Morb Mortal Wkly Rep. 2002;51:825-828.
15. Sejvar J, Leis A, Stokic D, et al. Acute flaccid paralysis associated with West Nile virus infection. Emerg Infect Dis. 2003;9:788-793.
16. Southern P, Smith J, Luby J, et al. Clinical and laboratory features of epidemic St Louis encephalitis. Ann Intern Med. 1969;71:681-689.
17. Monath T, Brinker K. The acute disease. In: Monath T, ed. St. Louis Encephalitis. Washington, DC: American Public Health Association; 1980:503-544.
18. Wasay M, Diaz-Arrastia R, Suss R, et al. St Louis encephalitis: a review of 11 cases in a 1995 Dallas, Texas, epidemic. Arch Neurol. 2000;57:114-118.
19. Huang C, Liu C, Chang Y, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936-942.
20. Goh K, Tan C, Chew N, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000;342:1229-1235.
21. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis. 2001;7:654-658.
22. Shieh W, Guarner J, Layton M, et al. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis. 2000;6:370-372.
23. Pradhan S, Pandey N, Shashank S, Gupta R, Mathur A. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology. 1999;53:1781-1786.
24. Shoji H, Watanabe M, Itoh S, Kuwahara H, Hattatori F. Japanese encephalitis and parkinsonism. J Neurol. 1993;240:59-60.
25. Murgod U, Muthane U, Ravi V, Radhesh S, Desai A. Persistent movement disorders following Japanese encephalitis. Neurology. 2001;57:2313-2315.
26. Misra U, Kalita J. Movement disorders in Japanese encephalitis. J Neurol. 1997;244:299-303.
27. Misra U, Kalita J. Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only. Postgrad Med. 2001;78:238-241.
28. Hokkanen L, Launes J. Cognitive outcome in acute sporadic encephalitis. Neuropsychol Rev. 2000;10:151-167.
29. Gordon B, Seines O, Hart J, et al. Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol. 1990;47:646-647.
30. Solomon T, Vaughn D. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. In: Mackenzie J, Barrett A, Deubel V, eds. Current Topics in Microbiology and Immunology: Japanese Encephalitis and West Nile Virus Infections. Vol. 267. Berlin, Germany: Springer-Verlag; 2002:171-194.
31. Leis A, Stokic D, Polk J, Dostrow V, Winkelmann M. A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med. 2002;347:1279-1280.
32. Glass J, Samuels O, Rich M. Poliomyelitis due to West Nile virus. N Engl J Med. 2002;347:1280-1281.
33. Modlin J, Coffey D. Poliomyelitis, polio vaccines, and the post-polio syndrome. In: Scheld W, Whitley R, Durack D, eds. Infections of the Central Nervous System. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:57-72.
34. Alcock A, Hildes J, Kaufert, et al. Respiratory poliomyelitis. CMAJ. 1985;130:1305-1310.
35. Tzeng S. Respiratory paralysis as a presenting symptom in Japanese encephalitis - a case report. Chinese Med J. 1989;43:208-212.